Hyperprolactinaemia, drug-induced


No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 E22.1#

1 out of 7 registries used, show all original rules.


diagram downward connector

Check minimum number of events None


diagram downward connector

Include endpoints None


diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC


diagram downward connector

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 E22
Name in latin Hyperprolactinaemia

Summary Statistics

Key figures

All Female Male
Number of individuals 160 138 22
Unadjusted prevalence (%) 0.04 0.07 0.01
Mean age at first event (years) 39.14 37.08 52.02


Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced

Endpoint not on priority list, no data to show.